Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 249

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Src Phosphorylates Tyr284 in TGF-β Type II Receptor and Regulates TGF-β Stimulation of p38 MAPK during Breast Cancer Cell Proliferation and Invasion

Galliher, Amy J., Schiemann, William P.·2007·Cancer Research

Abstract

Genetic and epigenetic events often negate the cytostatic function of transforming growth factor-β (TGF-β) in mammary epithelial cells (MEC), which ultimately enables malignant MECs to proliferate, invade, and metastasize when stimulated by TGF-β. The molecular mechanisms underlying this phenotypic conversion of TGF-β function during mammary tumorigenesis remain poorly defined. We previously established αvβ3 integrin and Src as essential mediators of mitogen-activated protein kinase (MAPK) activation, invasion, and epithelial-to-mesenchymal transition stimulated by TGF-β in normal and malignant MECs. Mechanistically, β3 integrin interacted physically with the TGF-β type II receptor (TβR-II), leading to its tyrosine phosphorylation by Src and the initiation of oncogenic signaling by TGF-β. We now show herein that Src phosphorylated TβR-II on Y284 both in vitro and in vivo. Interestingly, although the expression of Y284F-TβR-II mutants in breast cancer cells had no effect on TGF-β stimulation of Smad2/3, this TβR-II mutant completely abrogated p38 MAPK activation by TGF-β. Accordingly, Src-mediated phosphorylation of Y284 coordinated the docking of the SH2 domains of growth factor receptor binding protein 2 (Grb2) and Src homology domain 2 containing (Shc) TβR-II, thereby associating these adapter proteins to MAPK activation by TGF-β. Importantly, Y284F-TβR-II mutants also abrogated breast cancer cell invasion induced by αvβ3 integrin and TGF-β as well as partially restored their cytostatic response to TGF-β. Our findings have identified a novel αvβ3 integrin/Src/Y284/TβR-II signaling axis that promotes oncogenic signaling by TGF-β in malignant MECs and suggest that antagonizing this signaling axis may one day prove beneficial in treating patients with metastatic breast cancers. [Cancer Res 2007;67(8):3752–8]

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-06-3851

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 249

Metadata

Authors
Galliher, A. J., & Schiemann, W. P.
Venue
Cancer Research
Published
2007-04-15
Volume
67
Issue
8
Pages
3752-3758
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2057539625
Cited by
249
References
3
FWCI
4.67
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Src Phosphorylates Tyr284 in TGF-β Type II Receptor and Regulates TGF-β Stimulation of p38 MAPK during Breast Cancer Cell Proliferation and Invasion. https://app.cochat.ai/papers/10.1158/0008-5472.can-06-3851
The paper
Galliher, A. J., & Schiemann, W. P. (2007). Src Phosphorylates Tyr284 in TGF-β Type II Receptor and Regulates TGF-β Stimulation of p38 MAPK during Breast Cancer Cell Proliferation and Invasion. Cancer Research. https://doi.org/10.1158/0008-5472.can-06-3851

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.